Friedmann-Morvinski et al.69 showed that inhibition of NFKBIE in human GBMs is strongly associated with reduced cell proliferation and impaired tumor progression, making NFKBIE an attractive therapeutic target for GBM. The gene discussed is NFKBIE; the disease is neoplasm.